title: What is the optimal way to evaluate quality of life in breast cancer trials?
authors.affiliation: David Geffen School of Medicine at UCLA, Los Angeles, California.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Ganz
mesh_terms: D000367:Age Factors; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome